US Stock MarketDetailed Quotes

BioCryst Pharmaceuticals (BCRX)

Watchlist

8.770
-0.200-2.23%

Close May 19 15:59 ET

8.800
+0.030+0.34%

Post 20:01 ET

2.23BMarket Cap-4.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals (BCRX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-124.56%-61.79M

767.76%347.37M

5,700.61%291.96M

404.84%41.62M

3,119.15%41.3M

48.74%-27.52M

45.32%-52.02M

41.55%-5.21M

141.44%8.25M

92.73%-1.37M

Net income from continuing operations

-2,255,762.50%-721.81M

396.87%263.86M

1,017.50%245.85M

191.92%12.9M

140.12%5.09M

100.09%32K

60.77%-88.88M

56.59%-26.8M

61.18%-14.03M

83.17%-12.67M

Operating gains losses

--2.81M

--26.45M

--20.09M

--2.19M

----

Depreciation and amortization

39.27%461K

11.48%1.39M

27.51%394K

7.72%335K

2.81%329K

8.17%331K

-24.71%1.25M

-26.95%309K

-25.95%311K

-21.38%320K

Other non cash items

4,889.68%711.88M

-54.37%30.85M

-108.74%-1.23M

-78.47%3.13M

-25.12%14.68M

-26.61%14.27M

-21.21%67.61M

-28.08%14.04M

-34.30%14.53M

-17.36%19.6M

Change In working capital

-14.92%-71.4M

34.81%-56.9M

137.30%4.23M

85.00%-1.37M

112.99%2.38M

-28.05%-62.13M

-169.38%-87.28M

-162.60%-11.33M

43.62%-9.13M

-175.38%-18.3M

-Change in receivables

96.61%-474K

-62.16%-36.81M

-112.36%-15.49M

99.49%-17K

11.38%-7.31M

-264.34%-13.99M

-272.40%-22.7M

-145.66%-7.3M

-186.31%-3.32M

8.25%-8.25M

-Change in inventory

-457.13%-4.85M

60.64%-1.64M

76.19%-515K

-11.32%-1.69M

94.59%1.44M

28.69%-870K

-187.17%-4.16M

-338.48%-2.16M

55.11%-1.52M

-17.71%739K

-Change in prepaid assets

2,775.76%3.53M

-499.54%-7.83M

-437.46%-1.94M

-303.68%-5.92M

-90.83%160K

-111.93%-132K

128.72%1.96M

-19.15%574K

75.75%-1.47M

64.16%1.75M

-Change in payables and accrued expense

-85.29%-60.4M

291.19%57.8M

73.33%35.36M

33.50%24.58M

48.33%30.46M

26.87%-32.59M

17.92%14.78M

-58.54%20.4M

298.72%18.41M

11,022.87%20.54M

-Change in other current liabilities

41.78%-8.47M

11.31%-68.43M

42.28%-13.19M

13.75%-18.32M

---22.37M

---14.55M

-163.00%-77.16M

---22.85M

---21.24M

----

-Change in other working capital

---749K

----

Cash from discontinued investing activities

Operating cash flow

-124.56%-61.79M

767.76%347.37M

5,700.61%291.96M

404.84%41.62M

3,119.15%41.3M

48.74%-27.52M

45.32%-52.02M

41.55%-5.21M

141.44%8.25M

92.73%-1.37M

Investing cash flow

Cash flow from continuing investing activities

-1,091.50%-268.65M

-126.04%-13.69M

-569.11%-83.49M

59.88%13.57M

1,289.34%29.13M

-5.78%27.1M

140.00%52.59M

162.50%17.8M

-63.28%8.49M

87.13%-2.45M

Net PPE purchase and sale

-181.82%-403K

-119.57%-2.47M

-18.81%-802K

-2,177.97%-1.34M

-15.48%-179K

39.15%-143K

48.15%-1.12M

-21.84%-675K

94.02%-59K

66.81%-155K

Net business purchase and sale

---489.48M

---6.18M

----

--0

----

Net investment purchase and sale

712.23%221.24M

-110.41%-5.59M

-514.16%-76.5M

68.06%14.37M

1,377.51%29.31M

-6.05%27.24M

141.53%53.72M

166.16%18.47M

-64.54%8.55M

87.65%-2.29M

Net other investing changes

----

--550K

--0

----

Cash from discontinued investing activities

Investing cash flow

-1,091.50%-268.65M

-126.04%-13.69M

-569.11%-83.49M

59.88%13.57M

1,289.34%29.13M

-5.78%27.1M

140.00%52.59M

162.50%17.8M

-63.28%8.49M

87.13%-2.45M

Financing cash flow

Cash flow from continuing financing activities

77,887.15%412.55M

-5,974.14%-349.93M

-5,320.54%-217.96M

-4,716.48%-58.81M

-3,648.02%-73.69M

150.48%529K

-117.73%-5.76M

-26.73%-4.02M

4.00%1.27M

-106.70%-1.97M

Net issuance payments of debt

77,552.52%399.66M

-17,622.36%-301.99M

-51,747.47%-184.58M

-8,326.62%-46.85M

-17,323.88%-70.04M

-32.31%-516K

-102.92%-1.7M

69.44%-356K

---556K

-100.68%-402K

Net common stock issuance

450.00%33K

73.53%59K

360.00%23K

250.00%21K

-25.00%9K

-45.45%6K

-90.06%34K

-96.00%5K

-45.45%6K

-94.17%12K

Proceeds from stock option exercised by employees

715.02%19.48M

164.66%9.12M

212.12%657K

26.95%2.65M

1,195.83%3.42M

42.18%2.39M

-58.71%3.44M

-1,602.56%-586K

41.26%2.09M

-84.90%264K

Net other financing activities

-389.64%-6.62M

-658.01%-57.12M

-1,004.51%-34.06M

-5,505.36%-14.63M

-284.35%-7.07M

42.51%-1.35M

78.21%-7.54M

-41.99%-3.08M

0.38%-261K

---1.84M

Cash from discontinued financing activities

Financing cash flow

77,887.15%412.55M

-5,974.14%-349.93M

-5,320.54%-217.96M

-4,716.48%-58.81M

-3,648.02%-73.69M

150.48%529K

-117.73%-5.76M

-26.73%-4.02M

4.00%1.27M

-106.70%-1.97M

Net cash flow

Beginning cash position

-14.09%91.34M

-5.45%106.32M

----

12.12%89.93M

24.09%106.88M

-5.45%106.32M

-63.28%112.45M

-35.04%99.06M

-45.73%80.21M

-45.00%86.13M

Current changes in cash

76,641.12%82.11M

-213.34%-16.26M

----

43.68%-3.26M

100.41%107K

97.33%-5.19M

121.11%8.56M

304.95%18.01M

31.91%-5.78M

Effect of exchange rate changes

-115.96%-72K

235.68%1.27M

94.48%-72K

-154.99%-468K

1,050.35%1.36M

232.65%451K

-358.56%-936K

-349.81%-1.3M

236.36%851K

54.89%-143K

End cash Position

62.22%173.38M

-14.09%91.34M

----

12.12%89.93M

24.09%106.88M

-5.45%106.32M

-35.04%99.06M

-45.73%80.21M

Free cash flow

-124.85%-62.19M

748.99%344.9M

5,044.94%291.16M

392.06%40.28M

2,800.13%41.12M

48.70%-27.66M

45.39%-53.14M

37.84%-5.89M

139.20%8.19M

92.10%-1.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-124.56%-61.79M	767.76%347.37M	5,700.61%291.96M	404.84%41.62M	3,119.15%41.3M	48.74%-27.52M	45.32%-52.02M	41.55%-5.21M	141.44%8.25M	92.73%-1.37M
Net income from continuing operations	-2,255,762.50%-721.81M	396.87%263.86M	1,017.50%245.85M	191.92%12.9M	140.12%5.09M	100.09%32K	60.77%-88.88M	56.59%-26.8M	61.18%-14.03M	83.17%-12.67M
Operating gains losses	--2.81M	--26.45M	--20.09M	--2.19M	----	----	----	----	----	----
Depreciation and amortization	39.27%461K	11.48%1.39M	27.51%394K	7.72%335K	2.81%329K	8.17%331K	-24.71%1.25M	-26.95%309K	-25.95%311K	-21.38%320K
Other non cash items	4,889.68%711.88M	-54.37%30.85M	-108.74%-1.23M	-78.47%3.13M	-25.12%14.68M	-26.61%14.27M	-21.21%67.61M	-28.08%14.04M	-34.30%14.53M	-17.36%19.6M
Change In working capital	-14.92%-71.4M	34.81%-56.9M	137.30%4.23M	85.00%-1.37M	112.99%2.38M	-28.05%-62.13M	-169.38%-87.28M	-162.60%-11.33M	43.62%-9.13M	-175.38%-18.3M
-Change in receivables	96.61%-474K	-62.16%-36.81M	-112.36%-15.49M	99.49%-17K	11.38%-7.31M	-264.34%-13.99M	-272.40%-22.7M	-145.66%-7.3M	-186.31%-3.32M	8.25%-8.25M
-Change in inventory	-457.13%-4.85M	60.64%-1.64M	76.19%-515K	-11.32%-1.69M	94.59%1.44M	28.69%-870K	-187.17%-4.16M	-338.48%-2.16M	55.11%-1.52M	-17.71%739K
-Change in prepaid assets	2,775.76%3.53M	-499.54%-7.83M	-437.46%-1.94M	-303.68%-5.92M	-90.83%160K	-111.93%-132K	128.72%1.96M	-19.15%574K	75.75%-1.47M	64.16%1.75M
-Change in payables and accrued expense	-85.29%-60.4M	291.19%57.8M	73.33%35.36M	33.50%24.58M	48.33%30.46M	26.87%-32.59M	17.92%14.78M	-58.54%20.4M	298.72%18.41M	11,022.87%20.54M
-Change in other current liabilities	41.78%-8.47M	11.31%-68.43M	42.28%-13.19M	13.75%-18.32M	---22.37M	---14.55M	-163.00%-77.16M	---22.85M	---21.24M	----
-Change in other working capital	---749K	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-124.56%-61.79M	767.76%347.37M	5,700.61%291.96M	404.84%41.62M	3,119.15%41.3M	48.74%-27.52M	45.32%-52.02M	41.55%-5.21M	141.44%8.25M	92.73%-1.37M
Investing cash flow
Cash flow from continuing investing activities	-1,091.50%-268.65M	-126.04%-13.69M	-569.11%-83.49M	59.88%13.57M	1,289.34%29.13M	-5.78%27.1M	140.00%52.59M	162.50%17.8M	-63.28%8.49M	87.13%-2.45M
Net PPE purchase and sale	-181.82%-403K	-119.57%-2.47M	-18.81%-802K	-2,177.97%-1.34M	-15.48%-179K	39.15%-143K	48.15%-1.12M	-21.84%-675K	94.02%-59K	66.81%-155K
Net business purchase and sale	---489.48M	---6.18M	----	----	----	--0	--0	----	----	----
Net investment purchase and sale	712.23%221.24M	-110.41%-5.59M	-514.16%-76.5M	68.06%14.37M	1,377.51%29.31M	-6.05%27.24M	141.53%53.72M	166.16%18.47M	-64.54%8.55M	87.65%-2.29M
Net other investing changes	----	--550K	--0	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-1,091.50%-268.65M	-126.04%-13.69M	-569.11%-83.49M	59.88%13.57M	1,289.34%29.13M	-5.78%27.1M	140.00%52.59M	162.50%17.8M	-63.28%8.49M	87.13%-2.45M
Financing cash flow
Cash flow from continuing financing activities	77,887.15%412.55M	-5,974.14%-349.93M	-5,320.54%-217.96M	-4,716.48%-58.81M	-3,648.02%-73.69M	150.48%529K	-117.73%-5.76M	-26.73%-4.02M	4.00%1.27M	-106.70%-1.97M
Net issuance payments of debt	77,552.52%399.66M	-17,622.36%-301.99M	-51,747.47%-184.58M	-8,326.62%-46.85M	-17,323.88%-70.04M	-32.31%-516K	-102.92%-1.7M	69.44%-356K	---556K	-100.68%-402K
Net common stock issuance	450.00%33K	73.53%59K	360.00%23K	250.00%21K	-25.00%9K	-45.45%6K	-90.06%34K	-96.00%5K	-45.45%6K	-94.17%12K
Proceeds from stock option exercised by employees	715.02%19.48M	164.66%9.12M	212.12%657K	26.95%2.65M	1,195.83%3.42M	42.18%2.39M	-58.71%3.44M	-1,602.56%-586K	41.26%2.09M	-84.90%264K
Net other financing activities	-389.64%-6.62M	-658.01%-57.12M	-1,004.51%-34.06M	-5,505.36%-14.63M	-284.35%-7.07M	42.51%-1.35M	78.21%-7.54M	-41.99%-3.08M	0.38%-261K	---1.84M
Cash from discontinued financing activities
Financing cash flow	77,887.15%412.55M	-5,974.14%-349.93M	-5,320.54%-217.96M	-4,716.48%-58.81M	-3,648.02%-73.69M	150.48%529K	-117.73%-5.76M	-26.73%-4.02M	4.00%1.27M	-106.70%-1.97M
Net cash flow
Beginning cash position	-14.09%91.34M	-5.45%106.32M	----	12.12%89.93M	24.09%106.88M	-5.45%106.32M	-63.28%112.45M	-35.04%99.06M	-45.73%80.21M	-45.00%86.13M
Current changes in cash	76,641.12%82.11M	-213.34%-16.26M	----	----	43.68%-3.26M	100.41%107K	97.33%-5.19M	121.11%8.56M	304.95%18.01M	31.91%-5.78M
Effect of exchange rate changes	-115.96%-72K	235.68%1.27M	94.48%-72K	-154.99%-468K	1,050.35%1.36M	232.65%451K	-358.56%-936K	-349.81%-1.3M	236.36%851K	54.89%-143K
End cash Position	62.22%173.38M	-14.09%91.34M	----	----	12.12%89.93M	24.09%106.88M	-5.45%106.32M	-5.45%106.32M	-35.04%99.06M	-45.73%80.21M
Free cash flow	-124.85%-62.19M	748.99%344.9M	5,044.94%291.16M	392.06%40.28M	2,800.13%41.12M	48.70%-27.66M	45.39%-53.14M	37.84%-5.89M	139.20%8.19M	92.10%-1.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm